Vyas-Read S, Wang W, Kato S, Colvocoresses-Dodds J, Fifadara NH, Gauthier TW, Helms MN, Carlton DP, Brown LA. Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition. Am J Physiol Lung Cell Mol Physiol 306: L326 -L340, 2014. First published December 27, 2013 doi:10.1152/ajplung.00074.2013.-Myofibroblast accumulation is a pathological feature of lung diseases requiring oxygen therapy. One possible source for myofibroblasts is through the epithelial-to-mesenchymal transition (EMT) of alveolar epithelial cells (AEC). To study the effects of oxygen on alveolar EMT, we used RLE-6TN and ex vivo lung slices and found that hyperoxia (85% O2, H85) decreased epithelial proteins, presurfactant protein B (pre-SpB), pro-SpC, and lamellar protein by 50% and increased myofibroblast proteins, ␣-smooth muscle actin (␣-SMA), and vimentin by over 200% (P Ͻ 0.05). In AEC freshly isolated from H85-treated rats, mRNA for pre-SpB and pro-SpC was diminished by ϳ50% and ␣-SMA was increased by 100% (P Ͻ 0.05). Additionally, H85 increased H2O2 content, and H2O2 (25-50 M) activated endogenous transforming growth factor-␤1 (TGF-␤1), as evident by H2DCFDA immunofluorescence and ELISA (P Ͻ 0.05). Both hyperoxia and H2O2 increased SMAD3 phosphorylation (260% of control, P Ͻ 0.05). Treating cultured cells with TGF-␤1 inhibitors did not prevent H85-induced H2O2 production but did prevent H85-mediated ␣-SMA increases and E-cadherin downregulation. Finally, to determine the role of TGF-␤1 in hyperoxia-induced EMT in vivo, we evaluated AEC from H85-treated rats and found that vimentin increased ϳ10-fold (P Ͻ 0.05) and that this effect was prevented by intraperitoneal TGF-␤1 inhibitor SB-431542. Additionally, SB-431542 treatment attenuated changes in alveolar histology caused by hyperoxia. Our studies indicate that hyperoxia promotes alveolar EMT through a mechanism that is dependent on activation of TGF-␤1 signaling. lung fibrosis; oxidative stress; hyperoxia; oxygen therapy; transforming growth factor-␤1 signaling OXYGEN THERAPY PLAYS AN INTEGRAL ROLE in improving the health and survival of patients suffering from a wide range of pulmonary diseases, but sublethal oxygen exposure prevents normal healing and can lead to aberrant lung repair that culminates in alveolar epithelial hyperplasia, myofibroblast prominence, and continual matrix remodeling (30, 35, 43, 66) . In adult and neonatal animals, hyperoxia exposure increases epithelial damage, elevates cytokines, augments myofibroblast abundance, predisposes to collagen deposition, and culminates in fibrosis (1, 12, 19, 42, 50) . Recent proteomic investigations have demonstrated significant changes in cellular migration, differentiation, and proliferation proteins in alveolar epithelial cells (AEC) following hyperoxic injury (8). Although resident fibroblasts and circulating progenitors can certainly contribute to these pathological features, an additional source for pulmonary myofibroblast formation might be through the dedifferentiation of AEC through the process of epithelial-to-mesenchymal transition (EMT) (26, 54, 64, 69) .
OXYGEN THERAPY PLAYS AN INTEGRAL ROLE in improving the health and survival of patients suffering from a wide range of pulmonary diseases, but sublethal oxygen exposure prevents normal healing and can lead to aberrant lung repair that culminates in alveolar epithelial hyperplasia, myofibroblast prominence, and continual matrix remodeling (30, 35, 43, 66) . In adult and neonatal animals, hyperoxia exposure increases epithelial damage, elevates cytokines, augments myofibroblast abundance, predisposes to collagen deposition, and culminates in fibrosis (1, 12, 19, 42, 50) . Recent proteomic investigations have demonstrated significant changes in cellular migration, differentiation, and proliferation proteins in alveolar epithelial cells (AEC) following hyperoxic injury (8) . Although resident fibroblasts and circulating progenitors can certainly contribute to these pathological features, an additional source for pulmonary myofibroblast formation might be through the dedifferentiation of AEC through the process of epithelial-to-mesenchymal transition (EMT) (26, 54, 64, 69) .
EMT is a biologically important process that allows for tissue remodeling in the developing embryo, and this reversion of terminally differentiated epithelium to its mesenchymal roots has been implicated in organ fibrosis (36) . As cells lose their epithelial phenotype, they diminish junctional contacts with surrounding cells (through loss of E-cadherin), diminish epithelial protein expression, and forego apical-to-basal polarity. To allow for wound healing, epithelial characteristics are replaced by the expression of N-cadherin and vimentin to promote cellular migration, ␣-smooth muscle actin (␣-SMA) production to promote wound contractility, and collagen and fibronectin to promote extracellular matrix production (28) . In animal models and in human lung, alveolar cells undergoing EMT have been identified when type II-specific markers, such as surfactant proteins B and C (SpB and SpC), are coexpressed with mesenchymal proteins within single cells (33, 40, 45) . Several stimuli, such as cytokines, matrix components, and hypoxia, have been shown to have a role in inducing AEC into EMT (4, 14, 18, 27, 40, 41, 61) .
The effect of hyperoxia exposure on alveolar EMT has not been investigated. Oxidative stress generated from hyperoxia overwhelms cellular coping mechanisms and leads to the accumulation of reactive oxygen species (ROS). Pathological increases in intracellular ROS, such as superoxide, hydrogen peroxide (H 2 O 2 ), and hydroxyl radical, potentiate damage to proteins, lipids, and nuclear material and alter normal physiological processes (43) . Excessive quantities of any ROS are damaging to cellular processes, and, specifically, H 2 O 2 plays a role in profibrotic responses. In support of this, catalase degradation of hydrogen peroxide has been shown to protect against fibrosis in the lung (52, 63) . Oxidative stress from ROS, particularly H 2 O 2 , generated through insults such as cigarette smoke exposure, a hypoxic environment, and transforming growth factor-␤1 (TGF-␤1) signaling have been shown to induce EMT in the lung (20, 48, 73) .
Cumulative evidence suggests that TGF-␤1 is a primary regulator of EMT (49, 51) . Hyperoxia increases TGF-␤1 and its effector (Smad 3); indeed, inhibition of TGF-␤1 signaling attenuates hyperoxia-induced histopathology (1, 39, 50) . Conversely, AEC treated with exogenous TGF-␤1 assume a fibroblast-like morphology, lose epithelial protein expression, and acquire mesenchymal characteristics, suggesting EMT (40, 67, 70) . Although a link between ROS and/or TGF-␤1 and alveolar EMT has been established, it is still unclear whether hyperoxia can induce EMT in AEC and contribute to myofibroblast generation in the lung.
Herein, we first hypothesized that high oxygen exposure, or hyperoxia, serves as a "physiologic trigger" that alters alveolar epithelial homeostasis and promotes EMT. Next we determined whether hyperoxia-induced alveolar EMT is dependent on H 2 O 2 and/or endogenous TGF-␤1 activation. Changes in mesenchymal protein expression levels, evaluated in cultured cells, living lung slices, and in rodent animal models, support the hypothesis that oxygen-induced TGF-␤1 signaling contributes to myofibroblast abundance in the distal airways.
MATERIALS AND METHODS
Animals and in vivo treatments. All animal procedures were performed with the approval of the Institutional Animal Care and Use Committee at Emory University and performed in accordance with NIH guidelines. Two groups of adult male Sprague-Dawley rats were housed in identical Plexiglass chambers with either normal atmospheric oxygen (20.8%, referred to as control conditions) or 85% hyperoxia (H85) conditions (Proox model 110; Biospherix, Redfield, NY). A continuous oxygen monitor was used to assess oxygen concentrations, and animals were exposed to control conditions or hyperoxia for 7 days, or as indicated in the text. All animals had 12-h:12-h light/dark cycles and free access to water and a standard diet.
To evaluate the effects of TGF-␤ inhibition on EMT in vivo, four groups of adult Sprague-Dawley rats were subjected to the following experimental conditions for 7 days: 1) normal atmospheric oxygen (control) plus vehicle; 2) control plus SB-431542 (a TGF-␤ Alk 5 receptor inhibitor, 10 mg/kg in 400 l intraperitoneally every 48 h; Sigma, St. Louis, MO); 3) hyperoxia 85% plus vehicle; or 4) H85 plus SB-431542. At the end of exposure, AEC were isolated, double labeled with pro-SpC/vimentin for flow cytometry analysis, and lysed for protein evaluation of phospho-Smad 3/Smad 3 content, or the lungs were fixed and evaluated by immunohistochemistry.
AEC isolation. Sprague-Dawley rats were anesthetized with 60 -80 mg/kg pentobarbital sodium delivered intraperitoneally, and rat lung AEC were isolated using previously described methods (25) . Briefly, type II AEC were isolated and enzymatically digested using elastase (2.0 -2.5 U/ml; Worthington Biochemical, Freehold, NJ), followed by differential adherence on IgG-coated bacteriological plates. Using this experimental approach, primary AEC purities have been reported to be Ͼ90%. Harvested cells were plated in minimal defined serum-free media (10% CO 2 incubator at 37°C) and supplemented with 100 g/ml cis-OH-proline (Acros Organics, Geel, Belgium) for 24 -48 h to eliminate fibroblasts from the cultures as described (37) .
Cell culture. The immortalized rat lung epithelial cell line, RLE-6TN, was obtained from American Type Culture Collection (Manassas, VA) and maintained according to ATCC recommendations on 60-mm tissue culture plates (BD Biosciences, San Jose, CA). To determine the effects of plating density on hyperoxia-induced EMT, pairs of RLE-6TN cultures were plated at the same density in one of three different concentrations, 15,000 cells, 22,000 cells, or 30,000 cells. One plate from each pair was then treated with normal atmospheric oxygen, and the other was subjected to hyperoxia 85% for 4 days. Following treatment, the cells were fixed for later evaluation by immunofluorescence or hematoxylin and eosin (H&E) staining.
In vitro treatments. Control RLE-6TN cells were equilibrated with 5% CO 2-95% normal atmospheric oxygen, and hyperoxia-exposed cells were maintained under 5% CO 2-85% O2-10% normal atmospheric oxygen for the duration of treatment. An oxygen analyzer (Pacifitech Industries, Los Angeles, CA) was used to confirm the O 2 concentration in the incubator daily. Culture dishes were covered with a sterile, gas-permeable membrane (Diversified Biotech, Boston, MA) to allow equilibration of oxygen at the cellular surface. Media in control and hyperoxia-treated cells were changed every 24 -48 h.
In experiments in which primary AEC or RLE-6TN were treated with H 2O2, H2O2 (50 M) was prepared from a stock solution of 10 M, and was added directly to cell culture media every 24 h. For experiments designed to evaluate the effects of H 2O2 inhibition or TGF-␤1 inhibition on EMT, groups of control and hyperoxia-exposed cells were additionally treated with pegylated-catalase (500 U/ml; Sigma-Aldrich) or SB-431542 (2 mol/l) daily for 4 days.
To evaluate the effects of TGF-␤1-neutralizing antibody on ROSmediated EMT, RLE-6TN were cultured under control conditions, with H 2O2 (50 M), with H2O2 and a nonspecific mouse IgG (8 g/ml; Sigma-Aldrich), or with H 2O2 and a TGF-␤1-neutralizing antibody (8 g/ml; R & D Systems, Minneapolis, MN) for 4 days.
ROS determinations. In experiments designed to evaluate intracellular ROS, RLE-6TN were cultured and then exposed for 4 h to normal atmospheric oxygen and hyperoxia. Additional groups were pretreated for 30 min with pegylated-catalase (500 U/ml) or SB-431542 (2 mol/l) before hyperoxia exposure. Intracellular ROS were assessed by incubation with a ROS-sensitive fluorophore, carboxy-H2DCFDA (Image IT LIVE Green Reactive Oxygen Species Detection Kit; Invitrogen, Carlsbad, CA) and imaged using confocal microscopy. To ensure specificity of the carboxy-H2DCFDA, an additional group was treated with H 2O2 (as a positive control) and with H 2O2 and pegylated catalase (as a negative control).
Lung slice preparation. Lung slices were prepared using previously described methods without deviation (31) . After harvest, lung slices were placed in standard tissue culture dishes and maintained in Dulbecco's Modified Eagle's Medium/nutrient mixture Ham's F-12 supplemented with 10% fetal bovine serum, 35 mM/l HEPES, 2.5 mM L-glutamine, 0.5 ml/ml insulin-transferrin-sodium-selenite, 10 nM hydrocortisone, and 100 mg/ml primocin (InvivoGen, San Diego, CA) for 2 days. One group of slices was cultured in control conditions, and the other group was subjected to 85% hyperoxia, as described above for 2 days. Images are representative of at least three different fields from five independent experiments of control and hyperoxia-treated lung slice preparations.
Immunofluorescence. Following experimental treatment, lung slices or cellular cultures were fixed in an ice-cold acetone/methanol solution, washed, permeabilized with 0.2% Triton X-100, and blocked with antibody-reducing diluent for 20 min (Dako, Carpenteria, CA). Slices or cells were then incubated with primary antibodies overnight at 4°C followed by 1-h incubation in secondary antibodies. Primary antibodies used for immunofluorescence experiments include the following: mouse monoclonal ␣-SMA (Sigma), rabbit polyclonal ␣-SMA (Abcam, Cambridge, MA), mouse monoclonal E-cadherin (BD Transduction Laboratory, San Jose, CA), mouse monoclonal vimentin (SigmaAldrich), and mouse monoclonal lamellar protein (LP) (Abcam). Secondary antibodies were anti-mouse/rabbit IgG conjugated to Alexa 488 or Alexa 594 (Invitrogen). Lung slices or cellular cultures were transferred to glass slides and mounted using Prolong Gold with DAPI (Invitrogen).
Immunoblot analysis. RLE-6TN protein lysate concentrations were determined using the DC protein assay (Bio-Rad, Hercules, CA). Equal amounts of protein from control and treated samples were resolved on a 4%-20% Mini-Protean TGX precast gels (Bio-Rad) and electrophoretically transferred to nitrocellulose membranes (BioRad). Membranes were blocked for 2 h at room temperature with 5% nonfat dry milk in TBS with 0.2% Tween 20 and incubated with primary antibodies overnight at 4°C. Primary antibodies for immunoblot experiments include the following: mouse monoclonal ␣-SMA (Sigma), rabbit polyclonal N-cadherin (Cell Signaling, Danvers, MA), mouse monoclonal vimentin (Sigma-Aldrich), rabbit polyclonal proSpC (Millipore, Billerica, MA), mouse monoclonal pre-SpB (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal phosphoSmad3 (Cell Signaling), and rabbit polyclonal Smad 3 (Cell Signaling). Secondary anti-mouse or anti-rabbit IgG antibodies conjugated to horseradish peroxidase were applied for 1 h, and antibody complexes were visualized using enhanced chemiluminescence (ECL substrate; Thermo Scientific, Rockford, IL). GAPDH was measured as a loading control, densitometric analyses were performed, and protein abundance was normalized to GAPDH expression.
Confocal microscopy and image analyses. Confocal images were acquired using an inverted Olympus FLUOVIEW FV1000 IX81 (Olympus America, Center Valley, PA) microscope (ϫ40 -60 objective) and compatible analytical software. Z-stacks of 10 -20-m sections were obtained, with individual z-stacks representing 0.50-m-thin optical view sections. Pearson's correlation coefficient was used to determine the degree of coexpression between LP and ␣-SMA, as previously described (21) .
Flow cytometry. Single cell suspensions of isolated AEC (following 7-day treatment with control conditions or hyperoxia 85%) directly labeled with primary antibodies were analyzed on a BD FACSCanto II flow cytometer and associated DIVA software. Pro-SpC high AEC were identified in control populations and back-gated onto the forward and side-scatter profile of the population. The same gate was then copied into each experimental group. For analyses, primary antibodies against pro-SpC (Millipore) and vimentin conjugated to Alexa Fluor 647 (Santa Cruz Biotechnologies) were utilized. Pro-SpC was directly conjugated to rabbit IgG Alexa Fluor 488 using Zenon labeling to decrease nonspecific secondary antibody binding (Invitrogen).
Real-time PCR. RNA from freshly isolated control and hyperoxic AEC was isolated using a commercially available kit (RNAEasy; Qiagen, Valencia, CA). TaqMan gene expression assays were used to evaluate genes of interest ␣-SMA (Rn01759928_g1), N-cadherin (Rn0058099_m1), collagen-1␣ (Rn01526721_m1), E-cadherin (Rn00580109_m1), SpC (Rn00569225_ m1), and SpB (Rn00593742_m1). All cycle threshold results were normalized to the average of three housekeeping genes: ␤-microglobulin (Rn00560865_m1), ␤-actin (Rn00667869_m1), and ribosomal protein Lg (Rn00821065_g1). Fold change was calculated by determination of the 2
Ϫ⌬⌬CT between control and hyperoxia-exposed cells.
TGF-␤1 ELISA. RLE-6TN cells were treated daily with H2O2 (50 M) or mock-treated with media for 2-4 days. Total TGF-␤1 was determined by acidification of a portion of each treatment supernatant with 1 N HCl for 15 min followed by neutralization of the sample with 1 N NaOH. Active TGF-␤1 was measured in unacidified samples. Colorimetric determination of active and total TGF-␤1 (100 l) was assessed using a Synergy HT plate reader (Biotek, Winooski, VT) and TGF-␤1 E max ImmunoAssay System (Promega, Madison, WI) per the manufacturer's instructions [TGF-␤1 concentrations were normalized to the total cellular protein content (pg/mg protein)].
Immunohistochemistry. Specific groups of Sprague-Dawley rats treated with normal atmospheric oxygen or hyperoxia were additionally treated with intraperitoneal SB-431542 every 48 h (10 mg/kg). Following 7 days of treatment, rat tracheas were cannulated, and the lungs were lavaged with 3 ml of PBS to remove cells in the airways and alveolar space (for BAL cell counts). The lungs were then perfused, inflated with 3 ml of ambient air, and instilled with optimal cutting temperature compound (OCT) fixative. Animal lungs were snap-frozen in liquid nitrogen and stored in Ϫ80°C. Before use, 10-m sections of lungs were made and stained with H&E. Images were acquired using Olympus BX41 microscopy with a UPlan FLN ϫ10/0.3 lens.
Statistics. Statistical comparisons were performed using t-tests for analysis between two groups and using one-way ANOVA for experiments comparing three or more groups, using GraphPad Prism software. Values are means Ϯ SE. The level of significance was defined as P Ͻ 0.05.
RESULTS

Hyperoxia induces EMT.
We cultured immortalized rat lung epithelial type 2 cells, RLE-6TN, under normal atmospheric oxygen (control) or 85% hyperoxia (H85) environments for 4 days and compared the relative abundance of epithelial vs. mesenchymal cell proteins in control and H85-treated cells using confocal imaging (Fig. 1A) and Western blot analyses (Fig. 1B) . Under control conditions, E-cadherin, a junctional protein characteristic of epithelial cells, and LP were robustly expressed. H85 treatment, however, decreased E-cadherin and LP detection in RLE-6TN cells (Fig. 1A) . Immunoblot analyses of similarly maintained RLE-6TN cells (control) showed robust amounts of pre-SpB and pro-SpC. H85 exposure significantly reduced the quantities of pre-SpB and pro-SpC by ϳ50% by immunoblot ( Fig. 1B ; P Ͻ 0.05). Furthermore, H85 increased expression of ␣-SMA and vimentin, two proteins associated with EMT, above control levels (Fig. 1A) . In comparing the general morphology of the cells shown in Fig. 1A , it can be appreciated that hyperoxia exposure of RLE-6TN cells changed the cellular shape and led to a stellate cell morphology, which is atypical for control type II AECs. Moreover, Western blot analyses confirmed a 2.8-fold and 3.3-fold increase in ␣-SMA and vimentin expression, respectively, in hyperoxia-exposed cells ( Fig. 1B ; P Ͻ 0.05). Because surfactant secretion is an important function of normal healthy alveolar type 2 cells, the decrease in pro-SpC and pre-SpB detection and the gain of ␣-SMA and vimentin indicate loss of normal AEC characteristics in cultured cells exposed to hyperoxia.
Because previous reports have indicated that cellular density can affect the induction of EMT, we next cultured RLE-6TN at three plating densities (15,000 cells, 22,500 cells, and 30,000 cells) and exposed each cellular density to normal atmospheric oxygen or hyperoxia 85% (7, 44, 60) . On the initial day of treatment, control and hyperoxia-treated groups were seeded with the same number of cells. After 4 days of treatment, ␣-SMA, E-cadherin, and cellular morphology (by H&E) were evaluated by immunofluorescence and confocal microscopy. At each cellular density ( Fig. 2A) , hyperoxia exposure resulted in increased expression of ␣-SMA, loss of E-cadherin, and transition to a stellate morphology in cultured AEC.
To gain further evidence that hyperoxia-induced AEC differentiation into mesenchymal cells is relevant in vivo, we subjected adult rats to normal atmospheric oxygen (control) or 7 days of hyperoxia and then harvested RNA from freshly isolated type II AEC. Real-time PCR showed that hyperoxia significantly reduced epithelial gene expression of SpC, SpB, and E-cadherin to ϳ0.5-fold, indicating a loss of genes that regulate epithelial junctional integrity and function (Fig. 2B) . Moreover, in type II AEC isolated following hyperoxia exposure, the mesenchymal markers ␣-SMA, collagen I, and Ncadherin were increased at least twofold, when normalized to expression of SpC (Fig. 2 , C-E, P Ͻ 0.05).
To show that the changes reported above in Figs. 1 and 2 were not due to cell culture conditions, we next examined the effects of hyperoxia in situ using precision-cut lung slices in which the cells were maintained in their appropriate architecture. Adult rat lung slices were prepared and cultured under control conditions or subjected to H85 treatment for 2 days. Following exposure, the lung slices were colabeled for LP (to identify type II AEC, LPϩ) and ␣-SMA (to determine whether type II AEC were expressing mesenchymal proteins) (Fig. 3, A and B) . Using confocal imaging, we could visualize that H85-exposed lung slices (H85) had a significant number of single LP-ϩ type II cells that simultaneously expressed ␣-SMA protein, indicating that certain AEC were undergoing EMT (Dual ϩ). Next, line histograms were calculated using Olympus software to highlight the difference in ␣-SMA and LP expression within single cells in control and H85 slices. The bottom panel of Fig. 3A demonstrates the expression of ␣-SMA (red line) and LP (green line) in a single cell. Notably, the peaks of fluorescence for ␣-SMA are distinct from those for LP within this cell. In contrast, for hyperoxiatreated cells (Fig. 3B, bottom) , the red and green lines coincide, indicating coexpression of these proteins in a single cell. Overall, H85 significantly diminished LP intensity to 43% and increased ␣-SMA signal intensity 256%, when compared with control lung slices (Fig. 3C) . To further quantify specific AEC undergoing EMT, we manually counted the number of cells that coexpressed LP and ␣-SMA (Dual ϩ) relative to the number of LPϩ cells in each field. H85 increased the percentage of doubleϩ cells by fourfold from 3 Ϯ 1% in the control group to 12 Ϯ 2% coexpression in hyperoxia group (Fig. 2D , P Ͻ 0.05). To further quantify the number of dualϩ cells in control and H85-exposed lung slices objectively, we utilized confocal software to obtain statistical analyses using Pearson's correlation measurements for LP and ␣-SMA proteins. Pearson's correlation measurements confirmed that control AEC expressed both markers 2 Ϯ 1%, and hyperoxia increased double ϩ AEC by sixfold to 12 Ϯ 4% (Fig. 2E, P (72), we hypothesized that the effect of hyperoxia was mediated, at least in part, by H 2 O 2 . To address this question, we examined the effects of hyperoxia (85% O 2 for 4 h) on cultured RLE-6TN cells. First, we established that H85 treatment indeed increases ROS production over control levels in alveolar cells using confocal analysis and a ROS-sensitive fluorophore, carboxy-H2DCFDA (Fig. 4A) . The increased ROS induced by H85 was blocked by pegylated-catalase (500 U/ml), indicating that H85 increased the production of H 2 O 2 (Fig. 4A) . As a positive control, we demonstrated that H 2 O 2 -exposed RLE-6TN (50 M) had increased DCFDA signal and that it was inhibited by the addition of pegylated-catalase (Fig. 4A, right) .
We then investigated whether hyperoxia-induced EMT is mediated by H 2 O 2. Primary rat AEC were cultured under control conditions with or without H 2 O 2 (25 M), and epithelial and mesenchymal protein expression was assessed (Fig.  4B , top and top, middle). As was seen in hyperoxia-exposed cells, H 2 O 2 -significantly increased ␣-SMA and vimentin and decreased LP in primary rat AEC. Similar increases in ␣-SMA and vimentin and inhibition of LP expression were seen in RLE-6TN cultured with H 2 O 2 (50 M) for 4 days (Fig. 4B,  bottom and bottom, middle) . Western blot quantification of protein alterations showed that ␣-SMA, vimentin, and Ncadherin are more than doubled in H 2 O 2 -treated RLE-6TN, and the epithelial proteins of pre-SpB and pro-SpC are at least halved (Fig. 4C) . Thus hyperoxia increases H 2 O 2 within type II AEC, and H 2 O 2 may be a mechanism by which hyperoxia triggers EMT.
Hyperoxia and H 2 O 2 activate endogenous TGF-␤1. Because hyperoxia increases TGF-␤1 in the lung and TGF-␤1 can promote alveolar EMT, we next inquired whether TGF-␤1 signaling is involved in hyperoxia-induced EMT (1, 70) . The binding of active TGF-␤1 to its receptor signals the phosphorylation and activation of SMAD3, a transcription factor that promotes profibrotic repair in the lung (23). In Fig. 5 , we show the effects of hyperoxia and H 2 O 2 on TGF-␤1 and SMAD3 signaling in RLE-6TN, as determined by ELISA and Western blot. As shown in Fig. 5A, 2 days of H 2 O 2 treatment increased TGF-␤1 activation in a dose-responsive manner (control 225 vs. H 2 O 2 50 M 522 pg/mg protein, P Ͻ 0.05). Although total TGF-␤1 also increased, Fig. 5B demonstrates that the predominant effect was on activation, as the ratio of active to total TGF-␤1 increased from 0.2 to 0.53 in hyperoxia-exposed cells. To determine whether the increased active TGF-␤1 was accompanied by increased signaling, SMAD3 phosphorylation (p-SMAD3) was then assessed by Western blot. As seen in Fig.  5C , 2 days of hyperoxia increased the ratio of p-SMAD3 to total SMAD 6.7-fold over control values (P Ͻ 0.05). Likewise, H 2 O 2 treatment significantly increased p-SMAD3/SMAD3 expression 2.6-fold in RLE-6TN (Fig. 5D) .
To confirm that TGF-␤1 plays a causal role in ROS-induced alveolar EMT, we treated RLE-6TN with H 2 O 2 in the presence and absence of TGF-␤-neutralizing antibody (TGFnAb) and evaluated ␣-SMA and p-SMAD3 expression relative to control cells. Figure 6 , A and B shows that TGFnAb significantly attenuated H 2 O 2 -mediated increases in the mesenchymal protein, ␣-SMA, and prevented TGF-␤1 signaling through p-SMAD3. Immunofluorescence labeling of similarly treated RLE-6TN cells confirmed that the addition of TGFnAb prevented H 2 O 2 -induced upregulation of ␣-SMA (Fig. 6C, top) . Moreover, the addition of TGFnAb maintained normal Ecadherin expression despite the presence of H 2 O 2 (Fig. 6C,  bottom) .
Prior investigations have demonstrated that TGF-␤1 can generate ROS through the activation of NADPH oxidases in other cell types (11, 29) . To determine whether hyperoxiainduced H 2 O 2 generation was dependent on TGF-␤1 activity, we next cultured RLE-6TN in normal atmospheric oxygen, with H 2 O 2 (50 M) or with hyperoxia 85% for 2 days and inhibited TGF-␤1 receptor I with SB-431542 (2 mol/l) in some groups. ROS within cells were then evaluated using the carboxy-H2DCFDA assay described previously. Whereas control RLE-6TN had no baseline H 2 O 2 , the addition of exogenous H 2 O 2 increased intracellular ROS, and TGF-␤1-inhibition minimally attenuated this response (Fig. 6D, left and middle) . Interestingly, hyperoxia increased ROS within cells, but TGF-␤1 inhibition did not affect intracellular H 2 O 2 accumulation (Fig. 6D, right) . These above data indicate that H 2 O 2 promoted alveolar EMT, at least in part, through activation of endogenous TGF-␤1, but hyperoxia does not generate H 2 O 2 solely through the activation of TGF-␤1. However, we were still unclear whether TGF-␤1 was essential for hyperoxiamediated alveolar EMT.
Hyperoxia-induced alveolar EMT is mediated by TGF-␤1.
To address the question of the role of TGF-␤1 in hyperoxiainduced EMT in vivo, adult rats were housed for 7 days with control conditions or with hyperoxia (85%). Additional groups of rats exposed to control conditions or H85 were also treated with SB-431542 for the duration of the exposure. Freshly isolated AEC were colabeled for the epithelial proteins proSpC (conjugated to Alexa Fluor 488) and the mesenchymal protein, vimentin (conjugated to Alex Fluor 647), for simultaneous evaluation by flow cytometry. First, primary AEC that expressed high quantities of pro-SpC were identified from control animals and back-gated onto the forward and sidescatter profile of the type II cell population as shown in Fig. 7A . The gated subpopulation of pro-SpC highly positive cells was determined (quadrant 4, Q4, Fig. 7B ), and the same gate was copied into AEC from all experimental conditions. Then, we determined that type II AEC undergoing EMT were those that were simultaneously highly positive for pro-SpC and vimentin (quadrant 2, Q2, Fig. 7B ). Under control conditions, only 5 Ϯ 2% of pro-SpC-positive (type II AEC) cells also expressed vimentin (Fig. 7B) , and control animals treated with TGF-␤ inhibitor had a minor increase in cells that were doublepositive for pro-SpC and vimentin (12 Ϯ 1%, Fig. 7C ). In contrast, 46 Ϯ 16% of type II AEC cells (Q2) coexpressed pro-SpC and vimentin following H85 treatment ( Fig. 7D ; P Յ 0.05). In vivo inhibition of TGF-␤ in H85-exposed animals decreased pro-SpC and vimentin double-positive cells back to control levels of 12 Ϯ 4% ( Fig. 7E; P ϭ NS) . Conversely, the proportion of pro-C-high/vimentin-low cells (representing type II AEC) decreased from 95 Ϯ 2% under control conditions to 54 Ϯ 14% under hyperoxia conditions (Fig. 7F) . Interestingly, TGF-␤ inhibitor plus H85 increased pro-C-high/vimentin-low cells back to nearly the control values of 87 Ϯ 4%.
To ensure that the TGF-␤ inhibitor was reaching the lungs of H85-exposed animals and that TGF-␤ signaling was indeed being attenuated in type II AEC, p-SMAD3 was evaluated by Western blot in protein harvested from freshly isolated AEC from each of the four groups of animals above. In vivo SMAD3 phosphorylation increased 3 Ϯ 0.6-fold in freshly isolated AEC from hyperoxia-exposed animals but remained unchanged from control values in animals treated with H85 plus TGF-␤ inhibitor (Fig. 8A) . Baseline SMAD3 expression was similar between all the groups (Fig. 8A, bottom) 
. Hyperoxia increases H2O2 in AEC, and H2O2 promotes epithelial-to-mesenchymal transition (EMT).
A: RLE-6TN were cultured in normal atmospheric oxygen (Con), with hyperoxia 85% (H85), or with H2O2 (50 M), with and without pegylated-catalase (PEG-cat, 500 U/ml) for 4 h. Intracellular reactive oxygen species (ROS) were detected using carboxy-H2DCFDA fluorescence. B: with the use of confocal microscopy, ␣-SMA, vimentin, and LP were assessed in primary rat AEC exposed to H2O2 (25 M) for 7 days (top and top, middle in the gray box) and in RLE-6TN exposed to H2O2 (50 M) for 4 days (bottom and bottom, middle). All nuclei are DAPI labeled. Photomicrographs represent at least 3 independent experiments, original ϫ60 magnification (A and B). C: RLE-6TN treated with control media or media containing H2O2 had protein harvested and immunoblots for ␣-SMA, vimentin, N-cadherin, pre-SpB, and pro-SpC performed. Open bars represent normal atmospheric oxygen (20.8%), and solid bars represent H85-treated cells. Bar graphs represent at least 3 independent densitometric analyses relative to GAPDH expression. *P Ͻ 0.05.
data support that TGF-␤1 is downstream of H 2 O 2 and is essential to hyperoxia-induced alveolar EMT.
To confirm the role of ROS in hyperoxia-mediated EMT, RLE-6TN were then treated with hyperoxia (H85) alone, with pegylated-catalase, or with SB-431542, ␣-SMA, and E-cadherin and were evaluated using immunofluorescence and confocal microscopy. Figure 8B demonstrates that elimination of ROS and, separately, inhibition of TGF-␤1 signaling prevents hyperoxia-induced increases in ␣-SMA and downregulation of E-cadherin.
To determine the effects of TGF-␤1 inhibition on alveolar histology, lungs were harvested from rats treated with normal atmospheric oxygen or hyperoxia with or without SB-431541 for 7 days, fixed with OCT, and sectioned for immunohistochemistry. Figure 8C , left, demonstrates that control animals with and without TGF-␤1 inhibition had fine, reticular airspaces with minimal interstitial tissue. In contrast, H85-exposed animals had numerous alveoli with thickened interstitial spaces and increased H&E staining (Fig. 8C, top, right) . Animals with TGF-␤1 inhibition and H85 had less interstitial prominence that those animals treated with hyperoxia alone, but their lung architecture was not completely back to that of control animals (Fig. 8C, bottom, right) . Hyperoxia increased overall cell counts in the bronchoalveolar lavage of exposed animals, and this increase was not affected by TGF-␤1-inhibition (Fig. 8D) . Furthermore, the distribution of the types of cells between control and H85-treated animals in the presence or absence of TGF␤1-inhibition was not different. No neutrophils were seen in any experimental group (Fig. 8D, bottom) . These data demonstrate that TGF-␤1 inhibition improves interstitial tissue prominence in hyperoxia-exposed animals and that this improvement is not due to alterations in cell types in the airways and alveolar space.
DISCUSSION
Chronic oxygen exposure has been shown to increase myofibroblast abundance and extracellular matrix production in animal models and in human lung specimens, suggesting a fibroproliferative response to sublethal oxidative stress as a mechanism of repair (3, 12, 19) . Hyperoxia and its resulting ROS activate fibroblasts, resulting in H 2 O 2 production and increasing damage to neighboring epithelium, in a relative apoptosis resistance, and in a predisposition to extracellular matrix production (9, 54, 59, 68, 71) . The culmination of these aberrant processes is often alveolar remodeling and morbidity for the oxygen-treated patient (16, 17, 55) . In this study, we have found that one potential source of myofibroblast generation is the alveolar type II cell.
RLE-6TN cells treated with normal atmospheric oxygen, resided in a monolayer, had normal junctional proteins (Ecadherin), and maintained epithelial protein expression of surfactant and lamellar body proteins. In contrast, in hyperoxiaexposed AEC, surfactant proteins were more than halved, and this change was accompanied by a dramatic increase in ␣-SMA and vimentin. Similarly, when architecturally intact lung slices were subjected to hyperoxia, we were able to identify an increased proportion of type II cells that were simultaneously expressing ␣-SMA. The coexpression of both markers in the same cell was verified by manual counting of the cells in which proteins visually overlapped and by confocal statistical analyses that calculated the correlation of ␣-SMA and LP in a single plane. These results demonstrate that hyperoxia promotes EMT in type II cells located within an appropriate alveolar architecture and that this finding is not an artifact of the cell line model or cell isolation. Although hyperoxia treatment did reduce overall cellular number relative to controls, we found that that the effects of oxygen on ␣-SMA and E-cadherin expression and cellular morphology persisted despite alterations in initial seeding densities. Next, hyperoxia-induced EMT was supported in studies with freshly isolated AEC from animals exposed to hyperoxia in vivo. In this model, the process of EMT was verified by data demonstrating increased gene expression of collagen type I and N-cadherin, genes that are often upregulated in cells undergoing EMT (36) . Furthermore, we found that hyperoxia-treated AEC had 360% more N-cadherin transcription but 45% less E-cadherin. This "E-cadherin/N-cadherin" switch is characteristic of epithelial cells that are transitioning to a more migratory, mesenchymal state (5, 14) . Although their relative contribution to the total pool is debated, alveolar type II cells are thought to be one contributing source to the mesenchymal pool (62) . Therefore, it is important to understand which physiological or pathological conditions contribute to the EMT of alveolar type II cells. The current study demonstrates that, in some circumstances, prolonged or excessive oxygen use serves as the physiological trigger that induces epithelial cells to abandon their expression of junctional and surfactant proteins and to adopt more mesenchymal qualities. As such, hyperoxia may be an important contributor to myofibroblast abundance and fibroproliferative lung diseases in critically ill patients. Multiple factors may induce epithelial cells to acquire a myofibroblast phenotype, including cytokines (38, 47), matriceal factors (14, 18) , transcription factors (33, 57) , and cellular and growth factors (58, 65) . To examine the potential mechanisms by which hyperoxia could induce EMT, we first determined that hyperoxia increases hydrogen peroxide within cells and that hydrogen peroxide mediates EMT through the activation of TGF-␤1 and the canonical Smad pathway in a dose-dependent manner. Endogenous TGF-␤1 activation was necessary in our system as evidenced by the abrogation of ROS-induced EMT in the presence of a neutralizing antibody. The effects of ROS on TGF-␤1 activation are well-known (6) . TGF-␤1 is expressed in an autocrine and paracrine manner by AEC, and ROS can release active TGF-␤1 from the latency binding protein that keeps it quiescent (34, 56) . In animal models of hypoxia, TGF-␤1 activation, rather than expression, is essential to pulmonary vascular remodeling (24) . Furthermore, transfer of adenovirus containing active TGF-␤1 pro- analyses relative to GAPDH loading control, *P Ͻ 0.05 relative to control,^, X P Ͻ 0.05 relative to H85. B: immunofluorescence for ␣-SMA and E-cadherin in RLE-6TN treated with normal atmospheric oxygen (Con) or hyperoxia (H85), with and without pegylated-catalase or SB-431542 (TGF inhibitor). Photomicrographs are representative of 3 independent experiments at ϫ20 magnification. All nuclei are DAPI labeled, and secondary antibodies were conjugated to Alexa 488. C: H&E staining of the lungs of animals exposed to normal atmospheric oxygen or hyperoxia with and without SB-431542 for 7 days. Photomicrographs are representative of 3 independent experiments at ϫ10 magnification. D: total cellular counts in the bronchoalveolar lavage fluid (BAL) from animals treated in the 4 experimental groups (top) and percent distribution of cell types in the BAL from each group (bottom). Bar graphs represent the cumulative results of 3 independent experiments. motes lung fibrosis in neonatal animals (22) . In the current study, both hydrogen peroxide and hyperoxia increased activity of the SMAD3 transcription factor, again demonstrating TGF-␤1 activation under these conditions. Hyperoxia has been previously shown to increase TGF-␤ signaling in whole lung, and the importance of SMAD3 in lung fibrosis is apparent in that SMAD3 knockout animals are resistant to fibrogenesis (1, 10, 22, 50) . Interestingly, AEC exposed to high levels of oxygen Ͼ90% have less DNA damage when endogenous TGF-␤1 is activated, suggesting that it may also play a physiological role in maintaining alveolar homeostasis in the face of oxidative stress (2, 13) . Our initial studies support the concept that hyperoxia and subsequent H 2 O 2 activates endogenous TGF-␤1 in type II cells.
Because ROS can activate TGF-␤1 and TGF-␤ can promote the generation of ROS in cells through the induction of NADPH oxidases and through mitochondrial complex III, we next inquired whether TGF-␤1 was necessary for ROS generation in the presence of hyperoxia (29, 32, 46) . When cultured AEC were exposed to hyperoxia and treated with pegylatedcatalase, intracellular ROS were eliminated. However, AEC treated with hyperoxia and a TGF-␤1 inhibitor continued to accumulate intracellular ROS, suggesting that hydrogen peroxide production is upstream of TGF-␤1. Furthermore, in AEC isolated from animals that were treated in normal atmospheric oxygen with hyperoxia or with hyperoxia plus the TGF-␤1 inhibitor SB-431542, hyperoxia increased SMAD3 phosphorylation in alveolar cells in vivo, and this increase was dependent on TGF-␤1 receptor binding. Our data also showed that TGF-␤1 is essential for hyperoxia-induced EMT in animal lungs because inhibition of TGF-␤1 prevented mesenchymal marker expression, maintained pro-SpC levels, and improved alveolar architecture despite the presence of hyperoxia. Therefore, our in vitro and in vivo data show that hyperoxia promotes H 2 O 2 accumulation within alveolar epithelial cells and that ROS-mediated TGF-␤1 activation is essential for alveolar EMT to take place. Indeed, in breast cancer cells, the activation of NADPH oxidase-4 by TGF-␤1 and Smad activation is essential for EMT to occur (11) . Furthermore, a primary regulator of antioxidant defense, Nrf-2, has been shown to mediate NADPH oxidase-4 expression under hyperoxic conditions (53) . Although this study suggests that TGF-␤1 is downstream of ROS in hyperoxia-induced EMT, it is possible that TGF-␤1 activation further potentiates ROS generation through the activation of NADPH oxidase-4, leading to a vicious cycle.
In support of our findings, others have recently shown that H 2 O 2 can induce alveolar EMT in a human adenocarcinoma cell line and in bronchial epithelial cells (26) . To improve our understanding of EMT demonstrated in culture and to substantiate it in intact models (28), we have attempted to characterize the effects of hyperoxia on alveolar cells using a diverse range of in vitro, in situ, and in vivo techniques. In vivo demonstrations of EMT are similarly difficult to establish given that epithelial cells that are acquiring mesenchymal properties are simultaneously losing their epithelial ones. We have attempted to capture the effects of oxidative stress on epithelial cells in intact animals through the use of primary cell isolations, living lung slices, and flow cytometry analyses. A limitation of our investigations may be an underrepresentation of the contribution of alveolar cells on myofibroblast generation because our studies relied on the presence of SpC to establish an epithelial lineage. Additionally, TGF-␤1 activation certainly affects numerous signaling pathways to invoke EMT, including pathways involving MAP kinases, AKT, NF-B, SNAI, and hypoxia-inducible factor-1␣ depending on the circumstance (15) . In this study, we have chosen to examine one TGF-␤1-driven pathway that is classically associated with alveolar EMT.
The sequelae of injurious stimuli, including hyperoxia exposure, in the critically ill patient may contribute to long-term morbidity or mortality. Even though prolonged oxidative stress has long been associated with the development of pulmonary fibrosis in pediatric and neonatal patients and in animal models of disease, the routine use of oxygen therapy is prevalent in intensive care units as a life-saving measure. Our investigations have shown that a source of myofibroblast generation following hyperoxia exposure is the alveolar epithelium and that TGF-␤ activation is integral in this transition. Through an enhanced understanding of how oxidative stress affects signaling, cellular functioning, and interplay between cells, future studies may be able to pinpoint novel therapeutic targets for patients that suffer from the adverse effects of oxygen therapy.
